Free Trial
ASX:IDX

Integral Diagnostics (IDX) Stock Price, News & Analysis

Integral Diagnostics logo

About Integral Diagnostics Stock (ASX:IDX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
240,828 shs
Average Volume
N/A
Market Capitalization
$1.10 billion
P/E Ratio
N/A
Dividend Yield
1.95%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.

Receive IDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integral Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

IDX Stock News Headlines

Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.
Positive Report for Integral Diagnostics Ltd. (IDX) from Citi
See More Headlines

IDX Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Integral Diagnostics investors own include electroCore (ECOR), Dynavax Technologies (DVAX), CytoDyn (CYDY), Credit Suisse Group (CS), Chimerix (CMRX), Capricor Therapeutics (CAPR) and Bathurst Resources (BRL).

Company Calendar

Ex-Dividend for 4/6 Dividend
3/05/2025
Record date for 4/6 Dividend
4/06/2025
Dividend Payable
4/06/2025
Today
5/09/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
ASX:IDX
CIK
N/A
Fax
N/A
Employees
2,010
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
1.39
Net Income
$-60,700,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$469.70 million
Price / Cash Flow
23.99
Book Value
A$1.29 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.10 billion
Optionable
Not Optionable
Beta
0.73
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (ASX:IDX) was last updated on 5/9/2025 by MarketBeat.com Staff
From Our Partners